Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 22, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

Diffusion-driven device for a high-resolution dose-response profiling of combination chemotherapy.

Alexander Ganser1, Günter Roth, Joost C van Galen

  • 1Department of Biochemistry, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Analytical Chemistry
|May 30, 2009
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European expert recommendations for comprehensive pre-treatment, treatment-phase and post-treatment care of patients with metachromatic leukodystrophy treated with autologous haematopoietic stem and progenitor cell gene therapy.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same author

ADA2 genotype and enzyme activity may predict vasculitic or hematologic DADA2 phenotype.

Journal of human immunity·2026
Same author

Combined JAK- and TNFα-targeting in severe steroid-refractory graft-versus-host disease in children.

Bone marrow transplantation·2026
Same author

Overcoming methotrexate intolerance in a paediatric cohort of patients with rheumatic diseases: successful application of a large interval oral split-dose regimen.

Clinical and experimental rheumatology·2026
Same author

UV-induced mutations accumulate during early clonal expansion in aneuploid subtypes of pediatric B-cell precursor acute lymphoblastic leukemia.

Haematologica·2026
Same author

Virus-like and Virus Replicon Particles Targeting Multiple B-Cell Antigens Do Not Protect Against African Swine Fever Virus.

Vaccines·2026

A novel diffusion device simplifies testing drug combinations for HIV and cancer treatment. This innovation reduces steps and miniaturizes assays, accelerating the discovery of optimal combination therapies for personalized medicine.

Area of Science:

  • Biotechnology
  • Pharmacology
  • Oncology

Background:

  • Combination therapies are crucial for treating diseases like HIV and cancer.
  • Current methods for identifying and optimizing drug combinations are often experience-based and lack systematic screening.

Purpose of the Study:

  • To introduce a novel diffusion device for efficient creation and testing of dual-substance drug combinations.
  • To demonstrate the device's utility in drug screening and personalized medicine applications.

Main Methods:

  • A diffusion device compatible with 12-well microtiter plates was developed.
  • The device allows for the creation and testing of all binary mixtures with minimal pipetting steps.
  • Assays included MTT viability and fluorescence-based annexin V binding for cell death detection.

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Experiment Videos

Last Updated: Jun 22, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Main Results:

  • The diffusion device produced results comparable to standard MTT assays but with significantly fewer processing steps.
  • The device enables assay miniaturization, overcoming common challenges associated with small sample volumes.
  • Successful application in screening leukemia cell lines and primary patient cells was demonstrated.

Conclusions:

  • The diffusion device offers a simplified, miniaturized, and efficient platform for drug combination development and optimization.
  • This technology has the potential to significantly advance personalized medicine by identifying optimal drug combinations.
  • The ease of handling and reduced steps make it a valuable tool for researchers and clinicians.